Augment Biologics
Latest round
- Seed
Last raised
- Aug 2025
Total raised
- Undisclosed
Investors
- 1
About Augment Biologics
Augment Biologics Inc. is a biotech startup focused on glycoprotein-drug design using its innovative GlycoTemplating platform to enhance the efficacy and safety of biologics.Founded in 2024, Augment Biologics Inc. operates out of Cambridge, US, specializing in the development of glycoprotein-drug design. The company has engaged in one deal to date, with its most recent deal occurring on August 13, 2025.Augment Biologics Inc. specializes in glycoprotein-drug design through its proprietary platform, GlycoTemplating. This innovative technology allows for the site-specific incorporation of glycans into the primary sequences of biologics, enhancing their efficacy, safety, and durability. By addressing the challenges associated with traditional glycoengineering methods, GlycoTemplating transforms glycans from manufacturing risks into strategic design opportunities. The company targets a diverse range of applications, including antibody, protein, and peptide engineering, as well as long-term initiatives in RNA therapeutics, delivery vehicles, and vaccine development.Augment Biologics Inc. employs a transactional model primarily centered around collaborations and partnerships with biopharmaceutical entities. The company engages in B2B transactions, providing access to its GlycoTemplating platform under contractual agreements that may involve licensing fees or revenue-sharing arrangements based on the commercialization of developed biologics. Such partnerships may include tiered pricing structures that reflect the scale and complexity of the glycoprotein-drug development services provided. Specific flagship products associated with this platform enhance drug design processes, but detailed pricing information regarding individual services and contractual terms is not publicly disclosed.In August 2025, Augment Biologics Inc. Additionally, Augment is exploring expansion into European markets, with a targeted timeline for establishing partnerships and collaborations by mid-2026.
Who invested in Augment Biologics
1 investor across 1 round
See all investors in Augment Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Aug 13, 2025
Amount
Undisclosed
Investors
Questions about Augment Biologics
Who invested in Augment Biologics?
Augment Biologics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Augment Biologics raised?
Augment Biologics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Augment Biologics last raise money?
Augment Biologics's most recent round on record is a Seed, in Aug 2025.
Where is Augment Biologics headquartered?
Augment Biologics is headquartered in Cambridge, US.
Which VCs invest in companies like Augment Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back companies at Augment Biologics's stage. Their profiles are linked below.
VCs to look at next
Raising like Augment Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.